🌸
🌸
The Oak Tree
” The Oak Tree ” by Johnny R. Ryder
The Oak Tree
” The Oak Tree ” by Johnny R. Ryder
🌸
A mighty wind blew night and day.
It stole the Oak Tree’s leaves away.
But still the Oak Tree held its ground
while other trees fell all around.
The weary wind gave up and spoke,
"How can you still be standing Oak?”
The Oak Tree said, I know that you
can break each branch in two.
But I have roots stretched in the earth,
growing stronger since my birth.
Until today, I wasn’t sure
of just how much I could endure.
But now I’ve found with thanks to you,
I’m stronger than I ever knew.
🌸
Build your roots with the proper diet
and supplements
when you are healthy.
🌸
HERE ARE ...
All the Information you need ...
🌸
Secret of Longevity
Products for Longevity
🌸
A mighty wind blew night and day.
It stole the Oak Tree’s leaves away.
But still the Oak Tree held its ground
while other trees fell all around.
The weary wind gave up and spoke,
"How can you still be standing Oak?”
The Oak Tree said, I know that you
can break each branch in two.
But I have roots stretched in the earth,
growing stronger since my birth.
Until today, I wasn’t sure
of just how much I could endure.
But now I’ve found with thanks to you,
I’m stronger than I ever knew.
🌸
Build your roots with the proper diet
and supplements
when you are healthy.
🌸
HERE ARE ...
All the Information you need ...
🌸
Secret of Longevity
Products for Longevity
🌸
🌸
DEMENTIA
🌸
An Extremely Important Page
🌸
DEMENTIA
🌸
An Extremely Important Page
🌸
🌸
STUNNING TURNAROUND
🌸
DEMENTIA PATIENT REVIVES
AFTER MEGA-DOSE OF VITAMIN B1 ...
🌸
An 84-year-old suffering from advanced dementia given a high-dose Vitamin B1 regimen —
What happened next left doctors and caregivers speechless.
CLARITY. AWARENESS. MEMORY.
🌸
The fog lifted — and the spark returned. WHAT THIS MEANS:
Thiamine (Vitamin B1)
plays a critical role in brain function — especially in older adults.
🌸
Deficiency can mimic or worsen cognitive decline — yet it's rarely tested or treated.
High-dose therapy could be a game-changer for those written off by conventional medicine.
Big Pharma won’t talk about it. But stories like this are sparking a natural health awakening.
Maybe it’s not always hopeless.
Maybe the answer isn’t another pill — it’s nutrition.
STUNNING TURNAROUND
🌸
DEMENTIA PATIENT REVIVES
AFTER MEGA-DOSE OF VITAMIN B1 ...
🌸
An 84-year-old suffering from advanced dementia given a high-dose Vitamin B1 regimen —
What happened next left doctors and caregivers speechless.
CLARITY. AWARENESS. MEMORY.
🌸
The fog lifted — and the spark returned. WHAT THIS MEANS:
Thiamine (Vitamin B1)
plays a critical role in brain function — especially in older adults.
🌸
Deficiency can mimic or worsen cognitive decline — yet it's rarely tested or treated.
High-dose therapy could be a game-changer for those written off by conventional medicine.
Big Pharma won’t talk about it. But stories like this are sparking a natural health awakening.
Maybe it’s not always hopeless.
Maybe the answer isn’t another pill — it’s nutrition.
🌸
After 1 month of Thiamine
worked it up to 12OO mg ...
45O mg BENFO
35OHCL
4OO mg TTFD
Now we are up to 19OO mg
1OOO BENFO
4OO HCL
5OO TTFD
🌸
After 1 month of Thiamine
worked it up to 12OO mg ...
45O mg BENFO
35OHCL
4OO mg TTFD
Now we are up to 19OO mg
1OOO BENFO
4OO HCL
5OO TTFD
🌸
🌸
Vitamin B1 - Thiamin
🌸
To Order
🌸
https://www.swansonvitamins.com/p/swanson-premium-vitamin-b-1-thiamin-100-mg-250-caps
🌸
Vitamin B1 - Thiamin
🌸
To Order
🌸
https://www.swansonvitamins.com/p/swanson-premium-vitamin-b-1-thiamin-100-mg-250-caps
🌸
🌸
BENFO
https://www.swansonvitamins.com/p/swanson-
ultra-maximum-potency-benfotiamine-300-mg-60-veg-caps
BENFO
https://www.swansonvitamins.com/p/swanson-
ultra-maximum-potency-benfotiamine-300-mg-60-veg-caps
🌸
🌸
🌸
TTFD
or thiamine tetrahydrofurfuryl disulfide ...
is a thiamine derivative that is more readily absorbed than standard thiamine and is used to treat thiamine deficiency, with potential benefits for energy metabolism and physical performance.
🌸
TTFD
or thiamine tetrahydrofurfuryl disulfide ...
is a thiamine derivative that is more readily absorbed than standard thiamine and is used to treat thiamine deficiency, with potential benefits for energy metabolism and physical performance.
🌸
🌸
🌸
Videos on Dementia
🌸
Videos on Dementia
🌸
🌸
🌸
🌸
🌸
Don’t give up.
Don’t surrender your mind.
There is hope.
🌸
Don’t give up.
Don’t surrender your mind.
There is hope.
🌸
🌸
Youngevity Products
🌸
Youngevity Products
🌸
🌸
https://www.kindness2.com/products-for-longevity.html
🌸
In Powder Form
🌸
To Order
Call - 8OO 982 3189
EXT. 15O3
🌸
Use the Number ... 1O1O66744
for Reference Number
🌸
Recommended ... THE BEST
🌸
Beyond Tangy Tangerine
🌸
https://susanresner.youngevity.com/us_en/2point5.html?sku=USYG100074
🌸
https://www.kindness2.com/products-for-longevity.html
🌸
In Powder Form
🌸
To Order
Call - 8OO 982 3189
EXT. 15O3
🌸
Use the Number ... 1O1O66744
for Reference Number
🌸
Recommended ... THE BEST
🌸
Beyond Tangy Tangerine
🌸
https://susanresner.youngevity.com/us_en/2point5.html?sku=USYG100074
🌸
🌸
🌸
COMPARE the 2 PRODUCTS
🌸
https://onemindpsyberguide.org/youthful-brain-review/
🌸
https://thinkease.com/#gJ0krMTake
🌸
COMPARE the 2 PRODUCTS
🌸
https://onemindpsyberguide.org/youthful-brain-review/
🌸
https://thinkease.com/#gJ0krMTake
🌸
🌸
Fungal Infection in the Brain Produces Effects
Similar to Alzheimer's
🌸
Fungal Infection in the Brain Produces Effects
Similar to Alzheimer's
🌸
DEMENTIA & ALZHEIMER'S
Fungal Infection in the Brain Produces Effects Similar to Alzheimer's
Some researchers have suggested that neurodegenerative diseases like Alzheimer's, Parkinson's, and multiple sclerosis may have a microbial origin.
By Emma Suttie
A team of researchers at Baylor College of Medicine has discovered that when the brain is infected with a common fungus, it changes in ways similar to those seen in Alzheimer’s disease. The new research delves deeper into some of the molecular mechanisms behind that process.
The Study Findings
Using animal models, the research team discovered how the fungus, called Candida albicans (C. albicans), enters the brain, activates mechanisms for its clearance, and generates amyloid beta (Aβ)-like peptides—toxic protein fragments thought to be central to the development of Alzheimer’s disease.
The findings were published
Previous research has implicated fungi in the development of chronic neurodegenerative diseases like Alzheimer’s disease, but their mechanisms are not entirely understood.
A Microbial Cause of Alzheimer's?
A separate review published in the journal NeuroSci in 2022 explored the question of whether dementia has a microbial cause.
The report concluded that the reviewed data suggests infectious agents, like fungi, can play a role in the process through which Alzheimer’s disease and other forms of dementia develop.
Could Mold, Metals in Food, Our Own Bacteria Cause Alzheimer’s? How Do We Detox?
Could a Complex Carbohydrate Be the Key to Solving Alzheimer's?
“Our lab has years of experience studying fungi, so we embarked on the study of the connection between C. albicans and Alzheimer’s disease in animal models,” said Dr. David Corry, one of the study’s authors and a professor of pathology and immunology and medicine at Baylor College in a news release on Oct. 17. “In 2019, we reported that C. albicans does get into the brain, where it produces changes that are very similar to what is seen in Alzheimer’s disease. The current study extends that work to understand the molecular mechanisms.”
“Our first question was, how does C. albicans enter the brain? We found that C. albicans produces enzymes called secreted aspartic proteases (Saps) that breakdown the blood-brain barrier, giving the fungus access to the brain where it causes damage,” Yifan Wu, the study's lead author and a postdoctoral scientist in pediatrics said in a press release.
The researchers’ next goal was to determine how the brain was able to clear the fungal infection.
Dr. Corry and his colleagues had done previous research that showed an infection in the brain by C. albicans can be completely healed in ten days in healthy mice. Those findings, published in Nature Communications in January 2019 found that the fungal infection was cleared due to two mechanisms that were triggered by the fungus in specific brain cells called microglia.
When Neuropathy Hits, Try This (It's Genius!)
How Your Body Warns You That Dementia Is Forming
Microglia are a type of glial cell located throughout the brain and spinal cord and represent approximately 10–15 percent of the cells found in the brain. Microglia act as a primary line of immune system defense and scavenge the central nervous system for pathogenic organisms, damaged neurons, and other foreign material so they can be destroyed through a process called phagocytosis.
In the present study, the researchers demonstrated that Aβ-like peptides can be created by C. albicans. Candida albicans is a common fungus and has been found in the brains of people with Alzheimer’s disease as well as in those with other chronic neurodegenerative disorders.
What is Candida Albicans
Candida albicans is a common fungus (in the form of yeast) and is present in the gastrointestinal tract, the mouth, the skin, and the reproductive tract of most humans.
Humans and C. albicans have a complicated relationship, as most of the time, C. albicans is harmless and is simply a member of a healthy microbiota.
However, it is one of the few fungal species that cause disease in humans and is responsible for infections that range from superficial infections of the mucosa and skin, like thrush, diaper rash, and vaginal yeast infections, to more serious infections like invasive candidiasis that can affect the blood, heart, brain, and bones.
Infections by C. albicans are particularly dangerous for those with compromised immune systems, like those with AIDS, or people undergoing immunosuppressive therapies for cancer and other conditions.
This suppression of the body’s defenses is part of the reason why some people acquire C. albicans infections after taking antibiotics, as they decrease the beneficial bacteria in the gut, causing an imbalance and allowing C. albicans to thrive.
C. Albicans can survive outside the body and have the ability to colonize every human organ and tissue. According to the Encyclopedia of Microbiology, it is the most common cause of systemic fungal infections.
More Evidence Linking Fungi
to Neurodegenerative Diseases
In a January review published in Frontiers in Immunology, researchers examined the role of fungus in central nervous system autoimmune and neurodegenerative disorders.
The review states that recently, increasing evidence has pointed to the role of peripheral fungus in triggering inflammation, immune response, and worsening of a range of non-infectious disorders of the central nervous system (CNS), including multiple sclerosis, Parkinson’s, and Alzheimer’s disease.The review concluded that fungus can trigger inflammation via different mechanisms in the progression of CNS non-infectious diseases, suggesting that it is crucial for developing future therapeutic agents and strategies.
A 2015 study published in Scientific Reports states that several researchers have proposed the possibility that Alzheimer’s disease may have a microbial cause.
The researchers found evidence that tissue from the central nervous system (which includes the brain and spinal cord) of patients with Alzheimer’s disease contains fungal cells.
These fungal cells were found in different regions of the brain, including the external frontal cortex, cerebellar hemisphere, entorhinal cortex/hippocampus, and choroid plexus. These fungal materials were not present in the control individuals who did not have Alzheimer’s disease. The researchers identified several different species of fungus in their samples.
Story continues below Interestingly, the study authors noted that fungal infection was also found in the blood vessels, which could explain the vascular pathology that is often found in Alzheimer’s patients.
The findings provide intriguing evidence that these fungal infections are present in the central nervous systems of those with Alzheimer’s disease and not in healthy individuals who served as the controls.
Another Piece of the Puzzle
Dr. Corry and his colleagues have provided another piece to further understand the role fungus may play in the development of Alzheimer’s disease.“This work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer’s disease,”
Corry said in a press release. “The current explanation for this condition is that it is mostly the result of the accumulation of toxic Aβ-like peptides in the brain that leads to neurodegeneration. The dominant thinking is that these peptides are produced endogenously [internally], our own brain proteases break down the amyloid precursor proteins generating the toxic Ab peptides.”
However, in their study, the researchers show that these Aβ-like peptides can also be created from another source–candida albicans.
“These findings in animal models support conducting further studies to evaluate the role of C. albicans in the development of Alzheimer’s disease in people, which can potentially lead to innovative therapeutic strategies.” Dr. Corry said.
Fungal Infection in the Brain Produces Effects Similar to Alzheimer's
Some researchers have suggested that neurodegenerative diseases like Alzheimer's, Parkinson's, and multiple sclerosis may have a microbial origin.
By Emma Suttie
A team of researchers at Baylor College of Medicine has discovered that when the brain is infected with a common fungus, it changes in ways similar to those seen in Alzheimer’s disease. The new research delves deeper into some of the molecular mechanisms behind that process.
The Study Findings
Using animal models, the research team discovered how the fungus, called Candida albicans (C. albicans), enters the brain, activates mechanisms for its clearance, and generates amyloid beta (Aβ)-like peptides—toxic protein fragments thought to be central to the development of Alzheimer’s disease.
The findings were published
Previous research has implicated fungi in the development of chronic neurodegenerative diseases like Alzheimer’s disease, but their mechanisms are not entirely understood.
A Microbial Cause of Alzheimer's?
A separate review published in the journal NeuroSci in 2022 explored the question of whether dementia has a microbial cause.
The report concluded that the reviewed data suggests infectious agents, like fungi, can play a role in the process through which Alzheimer’s disease and other forms of dementia develop.
Could Mold, Metals in Food, Our Own Bacteria Cause Alzheimer’s? How Do We Detox?
Could a Complex Carbohydrate Be the Key to Solving Alzheimer's?
“Our lab has years of experience studying fungi, so we embarked on the study of the connection between C. albicans and Alzheimer’s disease in animal models,” said Dr. David Corry, one of the study’s authors and a professor of pathology and immunology and medicine at Baylor College in a news release on Oct. 17. “In 2019, we reported that C. albicans does get into the brain, where it produces changes that are very similar to what is seen in Alzheimer’s disease. The current study extends that work to understand the molecular mechanisms.”
“Our first question was, how does C. albicans enter the brain? We found that C. albicans produces enzymes called secreted aspartic proteases (Saps) that breakdown the blood-brain barrier, giving the fungus access to the brain where it causes damage,” Yifan Wu, the study's lead author and a postdoctoral scientist in pediatrics said in a press release.
The researchers’ next goal was to determine how the brain was able to clear the fungal infection.
Dr. Corry and his colleagues had done previous research that showed an infection in the brain by C. albicans can be completely healed in ten days in healthy mice. Those findings, published in Nature Communications in January 2019 found that the fungal infection was cleared due to two mechanisms that were triggered by the fungus in specific brain cells called microglia.
When Neuropathy Hits, Try This (It's Genius!)
How Your Body Warns You That Dementia Is Forming
Microglia are a type of glial cell located throughout the brain and spinal cord and represent approximately 10–15 percent of the cells found in the brain. Microglia act as a primary line of immune system defense and scavenge the central nervous system for pathogenic organisms, damaged neurons, and other foreign material so they can be destroyed through a process called phagocytosis.
In the present study, the researchers demonstrated that Aβ-like peptides can be created by C. albicans. Candida albicans is a common fungus and has been found in the brains of people with Alzheimer’s disease as well as in those with other chronic neurodegenerative disorders.
What is Candida Albicans
Candida albicans is a common fungus (in the form of yeast) and is present in the gastrointestinal tract, the mouth, the skin, and the reproductive tract of most humans.
Humans and C. albicans have a complicated relationship, as most of the time, C. albicans is harmless and is simply a member of a healthy microbiota.
However, it is one of the few fungal species that cause disease in humans and is responsible for infections that range from superficial infections of the mucosa and skin, like thrush, diaper rash, and vaginal yeast infections, to more serious infections like invasive candidiasis that can affect the blood, heart, brain, and bones.
Infections by C. albicans are particularly dangerous for those with compromised immune systems, like those with AIDS, or people undergoing immunosuppressive therapies for cancer and other conditions.
This suppression of the body’s defenses is part of the reason why some people acquire C. albicans infections after taking antibiotics, as they decrease the beneficial bacteria in the gut, causing an imbalance and allowing C. albicans to thrive.
C. Albicans can survive outside the body and have the ability to colonize every human organ and tissue. According to the Encyclopedia of Microbiology, it is the most common cause of systemic fungal infections.
More Evidence Linking Fungi
to Neurodegenerative Diseases
In a January review published in Frontiers in Immunology, researchers examined the role of fungus in central nervous system autoimmune and neurodegenerative disorders.
The review states that recently, increasing evidence has pointed to the role of peripheral fungus in triggering inflammation, immune response, and worsening of a range of non-infectious disorders of the central nervous system (CNS), including multiple sclerosis, Parkinson’s, and Alzheimer’s disease.The review concluded that fungus can trigger inflammation via different mechanisms in the progression of CNS non-infectious diseases, suggesting that it is crucial for developing future therapeutic agents and strategies.
A 2015 study published in Scientific Reports states that several researchers have proposed the possibility that Alzheimer’s disease may have a microbial cause.
The researchers found evidence that tissue from the central nervous system (which includes the brain and spinal cord) of patients with Alzheimer’s disease contains fungal cells.
These fungal cells were found in different regions of the brain, including the external frontal cortex, cerebellar hemisphere, entorhinal cortex/hippocampus, and choroid plexus. These fungal materials were not present in the control individuals who did not have Alzheimer’s disease. The researchers identified several different species of fungus in their samples.
Story continues below Interestingly, the study authors noted that fungal infection was also found in the blood vessels, which could explain the vascular pathology that is often found in Alzheimer’s patients.
The findings provide intriguing evidence that these fungal infections are present in the central nervous systems of those with Alzheimer’s disease and not in healthy individuals who served as the controls.
Another Piece of the Puzzle
Dr. Corry and his colleagues have provided another piece to further understand the role fungus may play in the development of Alzheimer’s disease.“This work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer’s disease,”
Corry said in a press release. “The current explanation for this condition is that it is mostly the result of the accumulation of toxic Aβ-like peptides in the brain that leads to neurodegeneration. The dominant thinking is that these peptides are produced endogenously [internally], our own brain proteases break down the amyloid precursor proteins generating the toxic Ab peptides.”
However, in their study, the researchers show that these Aβ-like peptides can also be created from another source–candida albicans.
“These findings in animal models support conducting further studies to evaluate the role of C. albicans in the development of Alzheimer’s disease in people, which can potentially lead to innovative therapeutic strategies.” Dr. Corry said.
🌸
Exercises to Relieve Painful Shoulder Impingement,
Restore Good Posture, and Prevent a Rotator Cuff Tear
Stroke Could Be Transmissible, Study Finds
Breakthrough Study ‘Infects’ Animals With Alzheimer’s Through Microbiome
COVID-19 Infection and Elevated Risk of Autoimmune and Inflammatory Diseases
How to Remain Nimble Throughout Old Age
Major Automakers Come Clean, Admit Americans Aren't Buying Electric Vehicles
Japanese Scientists Develop Groundbreaking Drug That Grows New Teeth
High Blood Pressure? Eat More Grapefruit
Molecule Found in Fruit and Nuts Restores Aging Immune System, New Study Finds
🌸
“This is a first
successful demonstration ...”
🌸
Exercises to Relieve Painful Shoulder Impingement,
Restore Good Posture, and Prevent a Rotator Cuff Tear
Stroke Could Be Transmissible, Study Finds
Breakthrough Study ‘Infects’ Animals With Alzheimer’s Through Microbiome
COVID-19 Infection and Elevated Risk of Autoimmune and Inflammatory Diseases
How to Remain Nimble Throughout Old Age
Major Automakers Come Clean, Admit Americans Aren't Buying Electric Vehicles
Japanese Scientists Develop Groundbreaking Drug That Grows New Teeth
High Blood Pressure? Eat More Grapefruit
Molecule Found in Fruit and Nuts Restores Aging Immune System, New Study Finds
🌸
“This is a first
successful demonstration ...”
🌸
Dr. Bredesen’s experience ...
As one example, in the case of the patient with the demanding job who was forgetting her way home, her therapeutic program ...
(1) eliminating all simple carbohydrates, leading to a weight loss of 20 pounds;
(2) eliminating gluten and processed food from her diet, with increased vegetables, fruits, and non-farmed fish;
(3) to reduce stress, she began yoga;
(4) as a second measure to reduce the stress of her job, she began to meditate for 20 minutes twice per day;
(5) she took melatonin each night;
(6) she increased her sleep from 4-5 hours per night to 7-8 hours per night;
(7) she took methylcobalamin each day;
(8) she took vitamin D3 each day;
(9) fish oil each day;
(10) CoQ10 each day; (11) she optimized her oral hygiene using an electric flosser and electric toothbrush;
(12) following discussion with her primary care provider, she reinstated hormone replacement therapy that had been discontinued;
(13) she fasted for a minimum of 12 hours between dinner and breakfast, and for a minimum of three hours between dinner and bedtime;
(14) she exercised for a minimum of 30 minutes, 4-6 days per week.
The results for nine of the 10 patients reported in the paper suggest that memory loss may be reversed, and improvement sustained with this therapeutic program, said Bredesen.
“This is the first successful demonstration,”
he noted, but he cautioned that the results are anecdotal, and therefore a more extensive, controlled clinical trial is needed.
The downside to this program is its complexity. It is not easy to follow, with the burden falling on the patients and caregivers, and none of the patients were able to stick to the entire protocol. The significant diet and lifestyle changes, and multiple pills required each day, were the two most common complaints. The good news, though, said Bredesen, are the side effects:
“It is noteworthy that the major side effect of this therapeutic system is improved health and an optimal body mass index, a stark contrast to the side effects of many drugs.”
The results for nine of the 10 patients reported in the paper suggest that memory loss may be reversed, and improvement sustained with this therapeutic program, said Bredesen.
https://www.buckinstitute.org/news/memory-loss-associated-with-alzheimers-reversed-for-first-time/?psafe_param=1&utm_source=google&utm_campaign=9875367091&utm_content=100538235095&utm_term=&utm_medium=431382012130&gad_source=1&gclid=Cj0KCQjwtJ6_BhDWARIsAGanmKcTcfiVtRRNCkToOlu5P_ck0D5a6iMpuntK8gl7c6S1GR_VauMcf6caAmdBEALw_wcB
As one example, in the case of the patient with the demanding job who was forgetting her way home, her therapeutic program ...
(1) eliminating all simple carbohydrates, leading to a weight loss of 20 pounds;
(2) eliminating gluten and processed food from her diet, with increased vegetables, fruits, and non-farmed fish;
(3) to reduce stress, she began yoga;
(4) as a second measure to reduce the stress of her job, she began to meditate for 20 minutes twice per day;
(5) she took melatonin each night;
(6) she increased her sleep from 4-5 hours per night to 7-8 hours per night;
(7) she took methylcobalamin each day;
(8) she took vitamin D3 each day;
(9) fish oil each day;
(10) CoQ10 each day; (11) she optimized her oral hygiene using an electric flosser and electric toothbrush;
(12) following discussion with her primary care provider, she reinstated hormone replacement therapy that had been discontinued;
(13) she fasted for a minimum of 12 hours between dinner and breakfast, and for a minimum of three hours between dinner and bedtime;
(14) she exercised for a minimum of 30 minutes, 4-6 days per week.
The results for nine of the 10 patients reported in the paper suggest that memory loss may be reversed, and improvement sustained with this therapeutic program, said Bredesen.
“This is the first successful demonstration,”
he noted, but he cautioned that the results are anecdotal, and therefore a more extensive, controlled clinical trial is needed.
The downside to this program is its complexity. It is not easy to follow, with the burden falling on the patients and caregivers, and none of the patients were able to stick to the entire protocol. The significant diet and lifestyle changes, and multiple pills required each day, were the two most common complaints. The good news, though, said Bredesen, are the side effects:
“It is noteworthy that the major side effect of this therapeutic system is improved health and an optimal body mass index, a stark contrast to the side effects of many drugs.”
The results for nine of the 10 patients reported in the paper suggest that memory loss may be reversed, and improvement sustained with this therapeutic program, said Bredesen.
https://www.buckinstitute.org/news/memory-loss-associated-with-alzheimers-reversed-for-first-time/?psafe_param=1&utm_source=google&utm_campaign=9875367091&utm_content=100538235095&utm_term=&utm_medium=431382012130&gad_source=1&gclid=Cj0KCQjwtJ6_BhDWARIsAGanmKcTcfiVtRRNCkToOlu5P_ck0D5a6iMpuntK8gl7c6S1GR_VauMcf6caAmdBEALw_wcB
🌸
My experience with 10 individuals diagnosed with Alzheimer's disease revealed a range of challenges and complexities, emphasizing the importance of individualized care and understanding the disease's progression.
Key Observations and Insights:
Key Observations and Insights:
- Varied Progression:
- The disease's progression differed significantly among individuals, with some experiencing a slower decline while others showed more rapid deterioration.
- Cognitive Decline:
Memory loss, difficulty with problem-solving, and challenges with language and communication were common, but the severity varied. - Behavioral Changes:
Individuals experienced mood swings, irritability, anxiety, and in some cases, agitation or aggression. - Impact on Daily Life:
Activities of daily living, such as dressing, bathing, and eating, became increasingly challenging as the disease progressed. - Importance of Communication:
Effective communication strategies, such as patience, non-verbal cues, and redirection, were crucial for managing challenging behaviors and maintaining a sense of connection. - Need for Specialized Care:
Many individuals required specialized care settings, such as memory care facilities, to ensure their safety and well-being. - Family Support:
The role of family members as caregivers was significant, and they often experienced emotional and physical strain. - Focus on Quality of Life:
Despite the challenges, it was important to focus on maintaining a sense of dignity and quality of life for individuals with Alzheimer's, through activities and interactions that were meaningful to them. - Early Detection Matters:
Early diagnosis and intervention can help individuals and their families plan for the future and access necessary support. - Ongoing Research:
Continued research into Alzheimer's disease is crucial for developing effective treatments and interventions.
🌸
